Observational study on off-label use of tocilizumab in patients with severe COVID-19

BACKGROUND: In December 2019 a novel coronavirus designated SARS-CoV-2 was identified, and the disease COVID-19 has caused many deaths. SARS-CoV-2 infection has been associated with the development of cytokine storm (including interleukin 6 (IL-6)), which can cause lung damage and lack of oxygen. To...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Hosp Pharm
Main Authors: Albertini, Laetitia, Soletchnik, Mickael, Razurel, Anais, Cohen, Johana, Bidegain, Frédéric, Fauvelle, Francis, Safrano, Geoffroy, Piquet, Jacques, Maurer, Cyril, Goldgran-Toledano, Dany
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2021
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7484788/
https://ncbi.nlm.nih.gov/pubmed/32912961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2020-002414
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker